Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Erin E. Bradt
OpenAlex ID:
A5049912083
Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis
2022
·
Eli Muchtar
, Morie A. Gertz
, et al.
·
Blood Advances
·
10
PDF
Show more works
View as search
Works count:
1
Citation count:
10
H-index:
1
I10-index:
1
Year
Topic
Type
